Milan, Italy

Emanuela Izzo




Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Gerenzano, IT (2013 - 2014)
  • Milan, IT (2013 - 2017)

Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Emanuela Izzo: Innovator in Pharmaceutical Sciences

Introduction

Emanuela Izzo, a distinguished inventor based in Milan, Italy, is making significant strides in the pharmaceutical industry. With a remarkable portfolio of 11 patents, she focuses her research on novel compounds that have the potential to address various health challenges.

Latest Patents

Among her latest innovations are the patents for Substituted 2-[2-(phenyl)ethylamino]alkaneamide derivatives. These compounds serve as sodium and calcium channel modulators, which are crucial in developing treatments for a broad spectrum of diseases. Notably, these derivatives are designed for pharmaceutical compositions that can prevent, alleviate, and cure an array of pathologies, including neurological, cognitive, psychiatric, inflammatory, urogenital, and gastrointestinal diseases.

Career Highlights

Emanuela is currently affiliated with Newron Pharmaceuticals S.p.a., where her expertise shapes the company's research and development initiatives. Her work in creating pharmaceuticals that can improve health outcomes showcases her commitment to innovation in medicine.

Collaborations

She collaborates closely with esteemed colleagues such as Piero Melloni and Alessandra Restivo, enhancing the innovative capabilities within her team. These partnerships are fundamental in driving forward-thinking solutions in the realm of pharmaceuticals.

Conclusion

Emanuela Izzo stands out as a key figure in the advancement of therapeutic inventions. Through her patents and collaborations, she contributes significantly to improving treatment options for various diseases, thereby leaving a lasting impact on the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…